Michael A. Rossi - 11 Jun 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Financial Officer
Signature: /s/ Michael A. Rossi
Issuer symbol: HBIO
Transactions as of: 11 Jun 2022
Net transactions value: -$24,984
Form type: 4
Filing time: 14 Jun 2022, 16:08:47 UTC
Previous filing: 03 Mar 2022
Next filing: 20 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Tax liability	$24,984	-6,325	-2.2%	$3.95	277,508	11 Jun 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on June 11, 2022.
F2	Include (a) 31,021 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 21,545 remaining restricted stock units that will vest on June 11, 2023, (c) 25,641 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 65,592 restricted stock units with performance based vesting conditions, (e) 23,878 remaining restricted stock units that will vest on July 18, 2022, (f) 21,545 remaining restricted stock units that will vest on December 29, 2022 and 2023, and (g) 88,286 shares of common stock beneficially owned by the Reporting Person.

Content

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on June 11, 2022.

Include (a) 31,021 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 21,545 remaining restricted stock units that will vest on June 11, 2023, (c) 25,641 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 65,592 restricted stock units with performance based vesting conditions, (e) 23,878 remaining restricted stock units that will vest on July 18, 2022, (f) 21,545 remaining restricted stock units that will vest on December 29, 2022 and 2023, and (g) 88,286 shares of common stock beneficially owned by the Reporting Person.